Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclophosphamide (cytoxan) (1 trial)
dendritic cells (1 trial)
ipilimumab (yervoy) (1 trial)
Prostatic Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (3 total)